Fuso Pharmaceutical Industries,Ltd. (TYO:4538)
Japan · Delayed Price · Currency is JPY 2,445.00
+85.00 (3.60%)
Mar 5, 2026, 3:30 PM JST
TYO:4538 Revenue
Fuso Pharmaceutical Industries,Ltd. had revenue of 17.04B JPY in the quarter ending December 31, 2025, with 12.69% growth. This brings the company's revenue in the last twelve months to 62.17B, up 12.20% year-over-year. In the fiscal year ending March 31, 2025, Fuso Pharmaceutical Industries,Ltd. had annual revenue of 60.56B with 9.31% growth.
Revenue (ttm)
62.17B
Revenue Growth
+12.20%
P/S Ratio
0.32
Revenue / Employee
45.38M
Employees
1,370
Market Cap
20.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 60.56B | 5.16B | 9.31% |
| Mar 31, 2024 | 55.41B | 6.80B | 13.98% |
| Mar 31, 2013 | 48.61B | 4.25B | 9.59% |
| Mar 31, 2012 | 44.36B | -3.11B | -6.55% |
| Mar 31, 2011 | 47.47B | 909.00M | 1.95% |
| Mar 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharma Foods International | 66.38B |
| Fuji Pharma | 54.57B |
| Daito Pharmaceutical | 51.20B |
| Koa Shoji Holdings | 23.66B |
| Morishita Jintan | 12.87B |
| Mizuho Medy | 11.26B |
| Wakamoto Pharmaceutical | 9.43B |
| Taiko Pharmaceutical | 6.40B |